chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Cough, Dyspnoea exertional, Fatigue, International normalised ratio increased
Clinical narrative: 87-year-old male with a PMH significant for AFib on warfarin, HTN, HLD, GERD, vaccinated x2 with Moderna who was diagnosed with covid-19 on Monday 1/10 at PCPs office. Confirmed with PCP, got molecular test, no prescriptions as outpatient. He reports experiencing tiredness and cough, very mild SOB with activity. Today, his O2 sat at home was reportedly 90-91%, he called his PCP and was advised to come to the ER for admission. In the ER, his O2 sat on arrival was 92% on RA, O2 sat during assessment 96-97% while talking. CXR negative for cardiopulmonary disease. Lab significant for transaminases AST 337/ALT 363, CRP mildly elevated, LDH 343, INR 4.18, troponins negative. Covid AG still pending collection.  He was admitted to medical for an Infectious Disease evaluation.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive, Transaminases, Troponin normal
Clinical narrative: 87-year-old male with a PMH significant for AFib on warfarin, HTN, HLD, GERD, vaccinated x2 with Moderna who was diagnosed with covid-19 on Monday 1/10 at PCPs office. Confirmed with PCP, got molecular test, no prescriptions as outpatient. He reports experiencing tiredness and cough, very mild SOB with activity. Today, his O2 sat at home was reportedly 90-91%, he called his PCP and was advised to come to the ER for admission. In the ER, his O2 sat on arrival was 92% on RA, O2 sat during assessment 96-97% while talking. CXR negative for cardiopulmonary disease. Lab significant for transaminases AST 337/ALT 363, CRP mildly elevated, LDH 343, INR 4.18, troponins negative. Covid AG still pending collection.  He was admitted to medical for an Infectious Disease evaluation.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Reconstitution of the vaccine was performed incorrectly using 0.9ml of NSS to reconstitute vaccine therefore dose of vaccine administered was double the prescribed dose.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 14 yo was given Moderna----on form mom put Moderna, and requested Moderna verbally to immunizer,  immunizer did not double check date of birth before shot--step was accidently overlooked
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Pt Admitted w/ AMS and COVID PNA on 3L O2, recieving remdesivir/dexamethasone
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Patient received 3 doses of COVID vaccine on 9/30/2021, 2/20/21 and 1/30/21 and was hospitalized from 1/14/22 - 1/16/22 with shortness of breath from COVID
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event, Product administered to patient of inappropriate age, Product administration error
Clinical narrative: No adverse event, administration error. Patient requested Moderna booster after her Pfizer series but is not old enough to get Moderna. Administering pharmacist did not catch she was too young until after the shot was administered.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Fall
Clinical narrative: Patient is very scared of needles.  Took her about 5 minutes to calm down and actually take the shot.  When she left the vaccine room she walked approximately 15 feet down an isle.  We heard someone call for help.  Patients mother said her daughter started to "go down".  Patient stayed on the floor for a few minutes and then was moved to a chair.  After sitting for about 15 minutes they left the store.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Condition aggravated, Hypophagia, Nausea, Pain
Clinical narrative: 33 y/o F w/ PMH significant for metastatic breast cancer w/ diffuse osseous lesions and hypercalcemia who presented to the ED w/ nausea, vomiting, and pain.  Pt stated that yesterday she started experiencing nausea and vomiting. Pt took metoclopramide for the nausea, which helped a little. Pt had 5-10 episodes of vomiting with PO intake. pt denies hematemesis or coffee ground emesis, pt endorses minimum bilious emesis, mainly food. Pt additionally states she is having severe generalized pain. This is her typical to her usual pain, however worsened given pt was not able to take PO pain medications. Pt stated her pain was 10/10 in the AM and was 8/10 on presentation. Pain was 6/10 during exam after pt received IV dilaudid.  Pt denies SOB, abdominal pain, chest pain, fever, cough, chills, sick contacts
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 33 y/o F w/ PMH significant for metastatic breast cancer w/ diffuse osseous lesions and hypercalcemia who presented to the ED w/ nausea, vomiting, and pain.  Pt stated that yesterday she started experiencing nausea and vomiting. Pt took metoclopramide for the nausea, which helped a little. Pt had 5-10 episodes of vomiting with PO intake. pt denies hematemesis or coffee ground emesis, pt endorses minimum bilious emesis, mainly food. Pt additionally states she is having severe generalized pain. This is her typical to her usual pain, however worsened given pt was not able to take PO pain medications. Pt stated her pain was 10/10 in the AM and was 8/10 on presentation. Pain was 6/10 during exam after pt received IV dilaudid.  Pt denies SOB, abdominal pain, chest pain, fever, cough, chills, sick contacts
Age: 34.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Urticaria
Clinical narrative: 24 hours later started to develop hives on different parts of the body. Called healthcare provider and took Benadryl and went to sleep. Woke two hours later with hives all over torso and starting to develop on face. When to ER and was given antihistamine and steroids and monitored. Went home after a couple hours as hives subsided. Took steroids and antihistamine prescriptions which helped. Had a few smaller hives the next day before starting prescriptions.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus, Sensation of foreign body, Urticaria
Clinical narrative: Swollen lymph nodes a day after Moderna COVID booster that lasted about 5 days . 9 days after booster extreme itching began in middle of night that caused rash hives after scratching that don't go away. Feeling like something is stuck in throat. Symptoms still present at time of writing this.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Upon reconsitution of the Pfizer vaccine 0.9ml of NSS used instead of 1.8ml, 0.3ml of the reconstituted solution pulled up for administration.  Double dose administered.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Alanine aminotransferase increased, Anticoagulant therapy, Aspartate aminotransferase increased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatinine increased, Blood lactic acid, Blood potassium increased, Blood sodium decreased, Blood urea increased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, COVID-19 pneumonia, Cardiac failure acute, Chest X-ray abnormal
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram thorax normal, Dyspnoea, Fibrin D dimer, Gait disturbance, Glomerular filtration rate decreased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ischaemic hepatitis, Nausea, Oedema, Oedema peripheral, Orthostatic hypotension
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Positive airway pressure therapy, Pulmonary fibrosis, Rhonchi, Sepsis
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Syncope, Tachypnoea, Transaminases increased, Ultrasound Doppler normal, Visual impairment
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatinine increased, Blood lactic acid, Blood sodium decreased, Blood urea increased, Brain natriuretic peptide increased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Breath sounds abnormal, C-reactive protein increased, COVID-19 pneumonia, Cardiac failure acute, Cardiac failure chronic
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram thorax normal, Condition aggravated, Dyspnoea, Dyspnoea at rest
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Emphysema, Fibrin D dimer, Gait disturbance, Glomerular filtration rate decreased, Hypertransaminasaemia
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ischaemic hepatitis, Nausea, Oedema peripheral, Orthostatic hypotension, Pain in extremity
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Positive airway pressure therapy, Pulmonary fibrosis, Refusal of examination, Rhonchi, Sepsis
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Syncope, Tachypnoea, Ultrasound Doppler normal, Visual impairment, White blood cell count increased
Clinical narrative: 11/30/21: Patient went to PCP with complaints of increasing SOB for weeks, nausea, syncopal events, increased edema and pain bilateral lower extremities. PCP diagnosed high suspicion for DVT/PE and recommended patient go to ER for evaluation. Patient refused. 12/1/21: Patient called EMS due to increased dyspnea and tachypnea, inability to ambulate without syncope. Arrived to ER with noted SOB at rest requiring 6L NC to sat 90%. RR 32-40, HR 110, +3 bilateral LE pitting edema, coarse rhonchi on auscultation throughout. Orthostatic hypotension in ER with BP 104/71 at rest then 75/49 upon standing with complaints of vision changes. During evaluation patient became suddenly unable to maintain oxygenation over 80%. despite increase in oxygen to 10L via HFNC.  Placed on BiPAP 10/5 FiO2 40% sat 98% with improved dyspnea.  CXR shows emphysema and diffuse pulmonary fibrosis.  NA 132, K5.5, eGFR 36 BUN/Creatine 34/2.5, AST 3214, ALT 1827, WBC 27.5, CRP 2.7, Lactic acid 8.7, d-dimer 856.  Admit with acute hypoxic respiratory failure and sepsis in the setting of COVID 19 PNA, new acute kidney injury with transaminitis, acute on chronic heart failure exacerbation, shocked liver.  Started on IV Lasix, rocephin, azythromycin, IV solumedrol, Lovenox, and home dulera, spiriva.  Remdesivir and baricitinib held due to AKI. 12/2/21:  CT negative for PE, dopplar negative for DVT.  RR 22-30, afebrile, HR 80, sat 93% on 6L via NC using BiPap at night 10/5 FiO2 40%.  BNP 2580 12/4/21:  ambulating in room on 4L NC sat 90%.  Sat 98% at rest.  RR 16-20, afebrile, SBP 90-110s.  No distress noted with speaking or ambulating.  BUN/Creating 42/1.2 eGFR >60, AST 332, ALT 1006. 12/5/21:  Patient to be discharged home on baseline home O2 of 4L.  Continue long steroid taper and have sleep study outpatient for new home CPAP at night.  WBC 14.7, BUN/Creating 22/0.9, ALT 711, AST 160.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on entire body
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Started initially with fatigue and underarm rash in left arm pit.. Continued with fever and aches, specifically near kidneys and lympnodes.  Large rash with elevated bump and redness/soreness approx 12-inch circumference at injection site.   Symptoms after 48 hrs. appear to be reducing slightly except for fatigue and achiness.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Started initially with fatigue and underarm rash in left arm pit.. Continued with fever and aches, specifically near kidneys and lympnodes.  Large rash with elevated bump and redness/soreness approx 12-inch circumference at injection site.   Symptoms after 48 hrs. appear to be reducing slightly except for fatigue and achiness.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Intracranial mass, SARS-CoV-2 test positive, Seizure
Clinical narrative: Hospitalized 1/7/2022 for a seizure and newly diagnosed brain mass, tested negative for COVID that date at an outside facility tested positive for COVID 1/11/2022 here.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 1/7/21 and 2/4/21. Positive on 1/5/22
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Blood lactic acid, Blood potassium decreased, COVID-19
Clinical narrative: 12/4/21:  Presented to ER with complaints of nausea/vomiting, decreased PO intake X6 days; body aches, cough/SOB, and generalized weakness.  Had a known COVID+ exposure on 11/23/21 from family.  Tested COVID+ on admission.  K3.2, WBC 5.0, Lactic acid 1.7.  HR 80s, RR 16-20, sat 100% on RA at rest down to 93% on RA with activity, BP 170/90, afebrile.  CXR linear opacities within lung bases.  CT negative for PE showing bilateral infiltrates consistent with COVID.  Admit with COVID 19 PNA.  Started on IV azithromycin, IV ceftriaxone, PO prednisone, remdesivir, Lovenox, and zofran. 12/7/21:  Uneventful hospitalization.  Remained afebrile and sat maintained >92% on RA throughout stay.  Discharged home.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Cough, Dyspnoea
Clinical narrative: 12/4/21:  Presented to ER with complaints of nausea/vomiting, decreased PO intake X6 days; body aches, cough/SOB, and generalized weakness.  Had a known COVID+ exposure on 11/23/21 from family.  Tested COVID+ on admission.  K3.2, WBC 5.0, Lactic acid 1.7.  HR 80s, RR 16-20, sat 100% on RA at rest down to 93% on RA with activity, BP 170/90, afebrile.  CXR linear opacities within lung bases.  CT negative for PE showing bilateral infiltrates consistent with COVID.  Admit with COVID 19 PNA.  Started on IV azithromycin, IV ceftriaxone, PO prednisone, remdesivir, Lovenox, and zofran. 12/7/21:  Uneventful hospitalization.  Remained afebrile and sat maintained >92% on RA throughout stay.  Discharged home.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Hypophagia, Lung infiltration, Lung opacity, Nausea
Clinical narrative: 12/4/21:  Presented to ER with complaints of nausea/vomiting, decreased PO intake X6 days; body aches, cough/SOB, and generalized weakness.  Had a known COVID+ exposure on 11/23/21 from family.  Tested COVID+ on admission.  K3.2, WBC 5.0, Lactic acid 1.7.  HR 80s, RR 16-20, sat 100% on RA at rest down to 93% on RA with activity, BP 170/90, afebrile.  CXR linear opacities within lung bases.  CT negative for PE showing bilateral infiltrates consistent with COVID.  Admit with COVID 19 PNA.  Started on IV azithromycin, IV ceftriaxone, PO prednisone, remdesivir, Lovenox, and zofran. 12/7/21:  Uneventful hospitalization.  Remained afebrile and sat maintained >92% on RA throughout stay.  Discharged home.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test positive, Vomiting, White blood cell count normal
Clinical narrative: 12/4/21:  Presented to ER with complaints of nausea/vomiting, decreased PO intake X6 days; body aches, cough/SOB, and generalized weakness.  Had a known COVID+ exposure on 11/23/21 from family.  Tested COVID+ on admission.  K3.2, WBC 5.0, Lactic acid 1.7.  HR 80s, RR 16-20, sat 100% on RA at rest down to 93% on RA with activity, BP 170/90, afebrile.  CXR linear opacities within lung bases.  CT negative for PE showing bilateral infiltrates consistent with COVID.  Admit with COVID 19 PNA.  Started on IV azithromycin, IV ceftriaxone, PO prednisone, remdesivir, Lovenox, and zofran. 12/7/21:  Uneventful hospitalization.  Remained afebrile and sat maintained >92% on RA throughout stay.  Discharged home.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Diarrhoea, Fatigue, Nausea
Clinical narrative: Patient tested + for COVID-19 today, presents with c/o body aches, chest pain, fatigue, nausea, vomiting, and diarrhea. Also discovered to have a pulmonary emboli.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pulmonary embolism, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Patient tested + for COVID-19 today, presents with c/o body aches, chest pain, fatigue, nausea, vomiting, and diarrhea. Also discovered to have a pulmonary emboli.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna on 4/12/21 and 5/10/21. Positive on 1/3/22
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus, loud ringing in my ears
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 6/1/21 and 6/22/21. Positive on 1/13/22
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Respiratory failure
Clinical narrative: Patient was hospitalized on 1/14/22 for resp. failure due to COVID.  patient remains hospitalized today, 1/17/22.  Patient has had 3 doses of COVID Pfizer vaccine on 12/28/21, 5/24/21 and 5/3/21
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Injection site pain, Malaise, Pyrexia
Clinical narrative: The next morning I woke up and my arm  at the injection site was a little sore which lasted about 36hrs and subsided on its on.  On 1/11 I thought I was developing a sinus infection because I began feeling real lousy.  I took a COVID test at home as protocol but it was negative.   Because I still wasn't feeling well I went to an Urgent Care and had another test and various other test performed but it too was negative.  I was prescribed a Z-pack and treated with Antibiotics and released.  At 10am the next morning the Urgent Care called back and advised I was in fact COVID positive, but was not a candidate to go to the hospital because my symptoms weren't bad enough to admitted so I am currently quarantining at home at this time.  This morning I woke up with a 101.9 fever and my blood O2 sat was at 84.  I reached out for assistance and two local reps came out  to my residence  this morning and check my vitals and theirs 02 sat read at 94.   I just received a call that I have now I am currently advised to take the GSK treatment and is currently awaiting to be transported to the Hospital to have that treatment as we speak
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: The next morning I woke up and my arm  at the injection site was a little sore which lasted about 36hrs and subsided on its on.  On 1/11 I thought I was developing a sinus infection because I began feeling real lousy.  I took a COVID test at home as protocol but it was negative.   Because I still wasn't feeling well I went to an Urgent Care and had another test and various other test performed but it too was negative.  I was prescribed a Z-pack and treated with Antibiotics and released.  At 10am the next morning the Urgent Care called back and advised I was in fact COVID positive, but was not a candidate to go to the hospital because my symptoms weren't bad enough to admitted so I am currently quarantining at home at this time.  This morning I woke up with a 101.9 fever and my blood O2 sat was at 84.  I reached out for assistance and two local reps came out  to my residence  this morning and check my vitals and theirs 02 sat read at 94.   I just received a call that I have now I am currently advised to take the GSK treatment and is currently awaiting to be transported to the Hospital to have that treatment as we speak
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure congestive, Condition aggravated, Diuretic therapy, Dyspnoea
Clinical narrative: Hospitalized with COVID (pos 1/9 symptomatic x 2 weeks)  and CHF exacerbation with orthopnea, dyspnea, and 15 # wt gain in 1 week.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Orthopnoea, SARS-CoV-2 test positive, Weight increased
Clinical narrative: Hospitalized with COVID (pos 1/9 symptomatic x 2 weeks)  and CHF exacerbation with orthopnea, dyspnea, and 15 # wt gain in 1 week.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Influenza A virus test, Influenza B virus test, Melaena, SARS-CoV-2 test positive
Clinical narrative: Presented with tarry stool from nursing home. Known Covid + for approximately 1 week at hospital.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chronic spontaneous urticaria, Erythema, Full blood count, Mechanical urticaria, Metabolic function test
Clinical narrative: Chronic spontaneous urticaria occurring daily. Dermatographia, pruritus, hives, erythema. Zyrtec improves symptoms within 30 minutes- more severe symptoms occur if Zyrtec is skipped. Occurs on scalp, face, neck, trunk, legs. Often worse at night
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Chronic spontaneous urticaria occurring daily. Dermatographia, pruritus, hives, erythema. Zyrtec improves symptoms within 30 minutes- more severe symptoms occur if Zyrtec is skipped. Occurs on scalp, face, neck, trunk, legs. Often worse at night
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Headache, Injection site pain
Clinical narrative: Pain at injection site, extreme weakness, headache, muscle pain, joint pain, nausea, back pain.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Pain at injection site, extreme weakness, headache, muscle pain, joint pain, nausea, back pain.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Visual impairment
Clinical narrative: leg weakness and vision difficulty admitted inpatient.